US Court Blocks Mailing of Abortion Medication to Restrict Access Nationwide

A federal appeals court has temporarily blocked the mailing of mifepristone, a medication used in abortion procedures. The ruling affects access to abortion pills nationwide.

The decision was made by a three-judge panel at the US Court of Appeals for the District of Columbia Circuit. The court’s order restricts the distribution of mifepristone through mail services.

Mifepristone is a medication that can be used in combination with another drug, misoprostol, to induce an abortion. It was previously approved by the FDA and made available for purchase online or at pharmacies.

The appeals court’s ruling does not immediately affect existing prescriptions of mifepristone. However, it may impact individuals seeking to obtain the medication through mail services in the future.

The decision is part of a broader debate over access to abortion procedures in the United States. The FDA had previously approved a rule allowing women to purchase abortion pills by mail. The appeals court’s ruling has been met with criticism from some groups advocating for reproductive rights.

The court’s order will remain in effect until further notice, and it may be appealed to the US Supreme Court.

Source: Google News World